GIBSON LANE PRACTICE — All Prescriptions & Medications — Page 13
Practice Code: B86036 | LEEDS, LS25 7JN
Showing results 601-650 of 669
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Glycopyrronium bromide | 12 | 1,320 | £1.3K | -41.5% ▼ |
| Glyceryl trinitrate | 12 | 360 | £446 | -9.7% ▼ |
| Colesevelam hydrochloride | 12 | 2,160 | £797 | -68.4% ▼ |
| Aclidinium bromide/formoterol | 12 | 12 | £369 | -65.9% ▼ |
| Valproic acid | 12 | 720 | £195 | -86.2% ▼ |
| Modafinil | 12 | 720 | £49 | -42.4% ▼ |
| Analgesics with anti-emetics | 12 | 252 | £81 | -15.2% ▼ |
| Phenobarbital | 12 | 4,368 | £2.4K | -61.0% ▼ |
| Mebendazole | 12 | 327 | £21 | +4.8% ▲ |
| Potassium chloride | 12 | 560 | £55 | -35.8% ▼ |
| Magnesium glycerophosphate | 12 | 1,080 | £2.9K | -12.7% ▼ |
| Azelastine hydrochloride | 12 | 96 | £73 | +1.0% vs avg |
| Acetic acid | 12 | 60 | £56 | +3.6% ▲ |
| Ipratropium bromide | 12 | 17 | £110 | -26.0% ▼ |
| Benzoyl peroxide | 12 | 360 | £62 | -14.8% ▼ |
| Amorolfine hydrochloride | 12 | 65 | £76 | -48.0% ▼ |
| 12 | 360 | £4.7K | +14.8% ▲ | |
| 12 | 2,320 | £114 | -52.3% ▼ | |
| 12 | 60 | £132 | +84.6% ▲ | |
| 12 | 1,350 | £281 | +19.5% ▲ | |
| 12 | 130 | £451 | +54.6% ▲ | |
| 12 | 140 | £686 | -14.2% ▼ | |
| Hydralazine hydrochloride | 11 | 1,176 | £69 | -73.9% ▼ |
| Telmisartan | 11 | 238 | £28 | -81.0% ▼ |
| Inclisiran | 11 | 11 | £580 | -12.7% ▼ |
| Clomipramine hydrochloride | 11 | 1,288 | £158 | -73.9% ▼ |
| Tranylcypromine sulfate | 11 | 616 | £10.7K | -3.5% ▼ |
| Clindamycin hydrochloride | 11 | 532 | £143 | +9.9% ▲ |
| Hydrocortisone sodium succinate | 11 | 11 | £11 | +188.8% ▲ |
| Oestrogens conjugated | 11 | 924 | £346 | -46.1% ▼ |
| Alprostadil | 11 | 89 | £833 | -35.7% ▼ |
| Ferric maltol | 11 | 616 | £524 | -15.4% ▼ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 11 | 27.6K | £816 | -58.6% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 11 | 5,940 | £91 | -52.0% ▼ |
| Pimecrolimus | 11 | 330 | £203 | -35.0% ▼ |
| Parecoxib sodium | 11 | 330 | £1.9K | +348.4% ▲ |
| 11 | 134 | £119 | -40.0% ▼ | |
| 11 | 292 | £1.3K | +71.3% ▲ | |
| 11 | 8,520 | £352 | -71.1% ▼ | |
| 11 | 19 | £310 | +61.7% ▲ | |
| 11 | 110 | £323 | -46.1% ▼ | |
| 11 | 930 | £2.6K | -25.6% ▼ | |
| 11 | 870 | £1.6K | -32.6% ▼ | |
| Nizatidine | 10 | 570 | £274 | -70.9% ▼ |
| Balsalazide sodium | 10 | 3,132 | £697 | -32.9% ▼ |
| Ketotifen fumarate | 10 | 3,000 | £164 | +14.9% ▲ |
| Frovatriptan | 10 | 120 | £286 | -29.3% ▼ |
| Rufinamide | 10 | 1,200 | £2.0K | -41.7% ▼ |
| Erythromycin ethylsuccinate | 10 | 868 | £150 | -57.2% ▼ |
| Levonorgestrel | 10 | 1,421 | £36 | +23.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.